Section Arrow
Quote
ENOV.NYSE
- Enovis Corp
Quotes are at least 15-min delayed:2025/04/29 23:57 EDT
Last
 34.91
+0.25 (+0.72%)
Day High 
35.39 
Prev. Close
34.66 
1-M High
38.56 
Volume 
791.74K 
Bid
34.5
Ask
41.56
Day Low
34.23 
Open
34.61 
1-M Low
29.315 
Market Cap 
1.98B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 33.04 
20-SMA 33.53 
50-SMA 37.04 
52-W High 56.43 
52-W Low 29.315 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-14.93/3.77
Enterprise Value
3.34B
Balance Sheet
Book Value Per Share
44.87
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
2.11B
Operating Revenue Per Share
29.08
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed：2025/04/29 23:57 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.